Target intelligence / Profile preview

Bacterial DNABII protein family (DNABII)

Target
DNABII
Molecular classification
DNA-binding protein, Nucleoid-associated protein, Histone-like protein
01

Overview

The Bacterial DNABII protein family, primarily comprising Histone-like protein (HU) and Integration host factor (IHF), consists of highly conserved DNA-binding proteins that are essential for the structural integrity of bacterial biofilms (Goodman et al., 2011, PNAS). While these proteins traditionally function as nucleoid-associated proteins (NAPs) involved in DNA bending and gene regulation within the bacterial cell, they are also actively secreted into the extracellular space. In the extracellular environment, DNABII proteins bind to and stabilize the scaffold of extracellular DNA (eDNA), acting as linchpins that maintain the integrity of the biofilm protective matrix (Devaraj et al., 2015, Microbiology Spectrum). This matrix protects bacteria from host immune defenses and increases their tolerance to antibiotic treatment by several orders of magnitude. Therapeutic strategies targeting the DNABII family, such as the monoclonal antibody TRL1068, aim to disrupt the biofilm architecture by sequestering these proteins, thereby releasing the bacteria into a planktonic state (Novotny et al., 2020, EBioMedicine). Once dispersed, the bacteria become significantly more susceptible to conventional antibiotic therapies and host immune clearance, offering a promising approach for treating chronic, recalcitrant infections.

Other names
Integration host factorIHFHistone-like proteinHUNucleoid-associated proteinsNAPs
02

Mechanism of action

Sequestration or removal of DNABII proteins from the extracellular biofilm matrix, which destabilizes the extracellular DNA (eDNA) scaffold, leading to biofilm collapse and increased susceptibility of bacteria to antibiotics and host immune clearance.

03

Biological functions

DNA bendingExtracellular DNA stabilizationBiofilm structural maintenanceGene regulationNucleoid architecture
04

Disease associations

Bacterial infectionChronic infectionCystic fibrosisOtitis mediaPeriodontitisUrinary tract infectionChronic wound infection
05

Safety considerations

Potential for systemic bacteremia upon rapid biofilm dissolutionRisk of systemic inflammatory response due to release of bacterial componentsPotential off-target effects on beneficial commensal bacteria
06

Interacting drugs

TRL1068
07

Biomarkers

Extracellular DNA (eDNA) levelsBiofilm densityBacterial load

Beyond the preview

Go deeper on Bacterial DNABII protein family (DNABII).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial DNABII protein family (DNABII).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call